$AAZ Geophysical Survey Generates Numerous High-Quality Targets at East Preston Project, Athabasca Basin



VANCOUVER, British Columbia, March 07, 2018 (GLOBE NEWSWIRE) -- AZINCOURT ENERGY CORP. (“Azincourt” or the “Company”) (TSXV:AAZ) (OTC:AZURF) is pleased to announce the completion of HLEM and Gravity geophysical surveys for the Company’s East Preston project, a highly prospective uranium project located in the western Athabasca Basin, Saskatchewan, with option partners Skyharbour Resources Ltd. and Clean Commodities Corp.
Numerous, high quality drill targets have been generated from the 50 line km surveys. Detailed interpretation work is underway to generate targets for future drill testing incorporating the detailed gravity survey results.
East Preston Program highlights
  • 50 line km of Horizontal Loop Electromagnetic (HLEM) and ground gravity surveys completed on multiple grids across the East Preston property (see Figure 1 Survey Map)
  • Excellent basement conductors confirmed and ground-truthed for follow-up – numerous targets identified on every grid surveyed
  • Detailed geophysical interpretation is on-going to qualify and prioritize drill targets for future drill testing using established Athabasca uranium deposit criteria
  • The Winter Exploration Program completed will satisfy year one of the JV Option with expenditures exceeding the agreement threshold
  • These positive results support the Company’s position to enter year two of the JV Option
East Preston Project 2017 Geophysical Results
Azincourt engaged a highly experienced geophysical consultant, Mr. Lawrence Bzdel, PGeo, to plan and oversee the geophysical surveys and interpret all recently acquired data alongside the historical exploration work and results.
Paterson Geophysics Ltd completed the 50 line km of HLEM survey work and MWH Geo-Surveys completed the 50 line km of ground gravity surveying based out of a temporary camp established on the project. Survey work was completed in January-February with camp and crew demobilization February 22.
The HLEM data was collected with a 200 m Transmitter-Receiver separation, and 50 m station intervals. The survey was designed to accurately identify multiple conductor systems in this shallow depth to basement environment. Unconformity-related uranium deposits are often associated in proximity to basement conductive trends and represent a first order criterion for discovery.
The Gravity survey recorded measurements at 50 m station intervals along grid lines. Subtle gravity low anomalies can highlight areas of alteration and structural disruption. Gravity highs may represent basement topography, which are also associated with unconformity-related uranium deposits. Initial interpretation work has confirmed the prospective, often highly complex, basement conductor architecture at East Preston. 
“We’re very encouraged with the work to date at East Preston,” said Alex Klenman, president & CEO.  “The Winter ground geophysical program generated numerous high-quality targets, establishing conductors and multiple conductor systems on all survey grids. This is very positive news and continues to speak directly to the excellent potential of the project,” continued Mr. Klenman. 
Detailed interpretation work will incorporate all data, historical and the present gravity and HLEM data to generate, rank and prioritize targets for future follow-up drill testing. Based on the interpreted number and quality of the conductor trends, the Company expects to generate enough targets for several drill programs.
East Preston JV Option
With the completion of the 2018 exploration program and accompanying interpretation work and reporting, Azincourt will have satisfied the exploration work commitment expenditure requirements for year one of the JV Option. The quality and number of targets identified at East Preston support the Company continuing the JV Option into year two.
Qualified Person
The technical information in this news release has been prepared in accordance with the Canadian regulatory requirements set out in National Instrument 43- 101 and reviewed on behalf of the company by Ted O’Connor, P.Geo. a director of Azincourt Energy Corp., as well as a qualified person.
About Azincourt Energy Corp.
Azincourt Energy is a Canadian-based resource company specializing in the strategic acquisition, exploration and development of alternative energy/fuel projects, including lithium, uranium, cobalt and other critical clean energy elements.  The Company is currently active at its joint venture lithium exploration projects in the Winnipeg River Pegmatite Field, Manitoba, Canada, and at its East Preston uranium project in the Athabasca Basin, Saskatchewan, Canada.
ON BEHALF OF THE BOARD OF AZINCOURT ENERGY CORP.
“Alex Klenman”                          
Alex Klenman, President & CEO
Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
This press release includes “forward-looking statements”, including forecasts, estimates, expectations and objectives for future operations that are subject to a number of assumptions, risks and uncertainties, many of which are beyond the control of Azincourt.  Investors are cautioned that any such statements are not guarantees of future performance and that actual results or developments may differ materially from those projected in the forward-looking statements.  Such forward-looking information represents management’s best judgment based on information currently available.  No forward-looking statement can be guaranteed, and actual future results may vary materially.
For further information please contact:
Alex Klenman, President & CEO
Tel: 604-638-8063
info@azincourtenergy.com
Azincourt Energy Corp.
430 – 800 West Pender Street
Vancouver, BC
V6C 2V6
www.azincourtenergy.com
Photos accompanying this announcement are available at

$CLSD Biotech Forum Daily Digest For March 7th

 Includes: CLSDDERMESPRFATEPTGXTTOOTTPH

Summary

Fears of a 'trade war' and a key departure from the current administration should put the market in a 'risk off' mode today, at least in early going.
Dermira implodes on a key Phase III trial failure. Clearside Biomedical and Tetraphase Pharmaceuticals get several positive mentions from analysts.
All the other notable news, events and analyst ratings from across the sector as well as a Spotlight feature on T2 Biosystems are below.
Love all, trust a few, do wrong to none.” ― William Shakespeare
The choppy nature of the market continues. After posting slight gains on Tuesday, the main biotech indices will open substantially down today as will the rest of the overall market.
Today's rally killer is the departure of Gary Cohn from the White House. Mr. Cohn was a key economic adviser and driver of the recently passed tax reform package. As importantly, his departure will weakened the free trade wing within the administration and makes a feared 'trade war' more likely in coming months. Not something that is going down well with investors.
Author's note: To get these Biotech Forum Daily Digests as soon as they are published, just click here on my profile, hit the big orange "Follow" button, and choose the "real-time alerts" option
Dermira (DERM) was the big loser in the sector on Monday. The shares lost over 60% of their value after the company announced that its Phase 3 trial for its compound olumacostat glasaretil or DRM01 failed to meet all co-primary endpoints in its two pivotal trials for the treatment of moderate-to-severe acne vulgaris. Dermira will not discontinue development for this program. The company does have another compound 'DRM04' that has a PDUFA date late in June to treat primary axillary hyperhidrosis.
Esperion Therapeutics (ESPR) should buck the downward tilt of the market today and get a decent lift from trial results it announced this morning. The company discloses that a Phase 3 trial for its bempedoic acid in statin-intolerant patients atherosclerotic cardiovascular disease or at high risk of ASCVD with elevated low-density lipoprotein cholesterol met its primary endpoint.
Protagonist Therapeutics (PTGX) rallied some five percent in trading on Tuesday. Its compound PTG-300 was designated as an Orphan Drug by the FDA for the potential treatment of beta-thalassemia, an inherited disorder characterized by chronic anemia due to impaired red blood cell production. Orphan Drug status conveys a seven-year period of market exclusivity for the indication, if the compound is eventually approved. PTG-300 recently successfully completed a Phase 1 clinical trial but is years away from any potential commercialization.
Piper Jaffray reiterated its Buy rating on Fate Therapeutics (FATE) Tuesday and doubled its price target to $20 on this emerging CAR-T concern. Jaffray's analyst believes lead allogeneic natural killer cell therapy FATE-NK100 'can enhance anti-tumor activity when combined with antibodies'. This compound is currently in three ongoing Phase 1 studies.

Not surprisingly given Monday's positive trial developmentsClearside Biomedical (CLSD) is seeing some love from analysts this week. On Monday, JMP Securities reissued its Outperform recommendation with $25 price target. Tuesday saw JP Morgan doing the same with a Buy rating $18 price target. The analyst at JMP Securities raised his price target from $21 a share previously on CLSD as he now sees the chances of eventual approval of CLS-TA moving to a 80% probability from 70% prior to this week's trial disclosure.

Tetraphase Pharmaceuticals (TTPH) also get some positive mention from analysts recently. Last week, Piper Jaffray reissued its Outperform rating and $8 price target on this small cap concern. After fourth quarter resultsyesterday, both H.C. Wainwright ($6 price target) and B Riley FBR reiterate their own Buy ratings on Tetraphase this morning. The company's compound eravacycline to treat complicated Intra-Abdominal Infections has a PDUFA date in late August with the FDA seeking approval.
Note: New analyst ratings are a great place to begin your due diligence, but nothing substitutes for deeper individual research in this very volatile sector of the market. Many of the small-cap names highlighted in "Analyst Insight" will eventually appear in the "Spotlight" section, where we do deeper dives on this type of promising but speculative small-cap concerns.
Today we provide an update on 'Busted IPO' T2 Biosystems (TTOO) whose shares have soared over the past week in today's Spotlight feature.
TTOO Stock ChartCompany Overview:
This company is a Massachusetts based diagnostics company that has developed a proprietary magnetic resonance technology platform that enables rapid detection of pathogens, biomarkers, and other abnormalities in patient fluids including blood, plasma, serum, saliva, sputum, and urine. The company was founded in 2006 and came public in August 2014 at $11.00 per share. Even with the stock's recent rally, the shares are far below their debut. Thus, TTOO is a 'Busted IPO', a niche in the market where I have found almost all of my 'ten-baggers' in my 30 plus years in the market. The stock currently has an approximate market capitalization of $225 million.
The Technology:
What I feels makes T2 Biosystems unique is its technology platform.
The company’s T2 magnetic resonance platform (T2MR) is a direct-from-sample diagnostic detection method. For molecular and immune-diagnostic targets, super paramagnetic particles with specie-specific target probes are introduced into a patient’s sample. If the target pathogen is present, the particles bind to it and cluster. This clustering alters the magnetic property of the sample water, which increases the T2MR signal, indicating the presence of the targeted pathogen. Because this technology works directly in the patient’s sample, no purification or extraction (culture) is required. As a result, none of the target pathogen is lost, providing a more sensitive and thus more accurate result. The company’s detection device, the T2Dx Instrument can run 7 tests at once and between 2,500 and 3,000 per annum.
This device has the potential to be a game changer in the detection of sepsis. Domestic deaths from sepsis annually (> 200,000) are more than breast cancer, prostate cancer, and AIDS combined. Sepsis related costs are about six percent of the overall hospital costs in this country, nearly $25 billion a year.
Sepsis is a severe inflammatory response to 25 different bacterial or 5 different fungal (Candida). A panel for Candida has been approved and is in the market. It can return a result in less than five hours, compared to an average of five days of the previous process. Each of these T2Dx machines cost ~$100,000 and currently employ only the T2Candida Panel. T2 Biosystems supplies the machines and the panels that much be restocked as tests are run. A true razor & razor blade story.
On September 11th, the company submitted a marketing application for a second panel. This would bump up the amount of different types of sepsis the T2Dx Instrument could detect to nearly 95% of the total from just over 10% with the T2Candida panel currently approved (fungal). Obviously, this is a game changer and should result in a big increase in sales of machines (razors) and panels (razor blades). This panel is already approved in Europe and should be approved in the United States soon. It takes generally six to months to approve this sort of device in the States.
Analyst Commentary & Balance Sheet:
Despite the company potential, there is little analyst commentary around this name. The only new analyst rating in the last nine months was from H.C. Wainwright in Mid-February. They chimed in and reiterated their Buy rating and $8 price target three weeks ago. The stock has staged a ~50% rally since then. The company ended the fourth quarter with just over $40 million in cash and marketable securities on the balance sheet. Management stated this gave it a cash runway for at least 12 months.
Verdict:
The new panel will detect a much greater percentage of sepsis pathogens (~95%) compared with current methods (50% to 65%) and will be do it in under six hours compared to the current three day average. This should spur much faster adoption as hospitals buy the machines and start to use the panels. I continue to think TTOO will be an amazing growth story over the next decade.
To be trusted is a greater compliment than being loved.” ― George MacDonald
Disclosure: I am/we are long derm,fate, ttoo, ttph.
I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Editor's Note: This article covers one or more stocks trading at less than $1 per share and/or with less than a $100 million market cap. Please be aware of the risks associated with these stocks.
Note: To get these types of articles on attractive biotech and pharma stocks as soon as they are published, just click here to "Follow" me and choose the real-time alerts option. This will also provide exclusive notification & access to the 5-7 instablogs around investment and trading ideas I send out ONLY to my real-time followers on a given week.   

$AAZ.V Azincourt Energy Outlines Upcoming Manitoba Lithium Work Programs

Figure 1 – Spodumene showing from the Eagle Pegmatite at the Lithium Two project
Azincourt Energy Corp

VANCOUVER, British Columbia, Feb. 01, 2018 (GLOBE NEWSWIRE) -- AZINCOURT ENERGY CORP. (“Azincourt” or the “Company”) (TSX.V:AAZ) is pleased to provide an update on its upcoming exploration work programs with partner New Age Metals Inc. (TSX.V:NAM) at the five newly acquired lithium projects in the Winnipeg River Pegmatite Field, Manitoba, Canada.
The Winnipeg River Pegmatite Field is host to numerous lithium-rich pegmatites in addition to the world-class Tanco Pegmatite, a highly fractionated lithium-cesium-tantalum (LCT) type pegmatite that has been mined at the Tanco Mine since 1969 in varying capacities for spodumene (a major rock unit for lithium (Li)), tantalum (Ta), cesium (Cs), rubidium (Rb), and beryllium (Be) ores.
Exploration work is scheduled to begin in late March (or early April, depending on weather), with a field program that includes detailed mapping of known pegmatite outcroppings on the Lithium One and Lithium Two projects.  This will be followed immediately by a comprehensive chip sampling program designed to prioritize targets for the initial drill programs anticipated at both properties during the months of May, June and July.
The Lithium Two project, adjacent to Quantum Minerals Corp Cat Lake Lithium Project (aka Irgon Lithium Mine), includes an historical estimate* from drilling in 1947 that defined 545,000 tonnes of 1.4% Li2O, drilled to a depth of 60 meters.  Field work in 2016 confirmed that the Eagle and FD5 Pegmatites contained significant surface spodumene.  The Eagle Pegmatite is approximately 1100 meters in length, up to 12 meters wide and open to depth.
12 samples collected in 2016 returned a range of 0.02% to 3.04% Li2O from the Eagle Pegmatite, and up to 2.08% Li2O from the FD5 Pegmatite.  Select sampling will concentrate on the Eagle and FD5 pegmatites at Lithium Two, and on the Silverleaf Pegmatite at Lithium One, which returned values as high as 4.33% Li2O in the 2016 exploration program.
Figure 1 – Spodumene showing from the Eagle Pegmatite at the Lithium Two project is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/6c43d76b-7633-4a5f-b62d-c2fe6289be39
* Note: The mineral reserve estimate cited above as part of the Lithium Two project is presented as a historical estimate which does not conform to current NI43-101 standards. A qualified person has not done sufficient work to classify the historical estimate as current mineral resources or mineral reserves. Although the historical estimates are believed to be based on reasonable assumptions, they were calculated prior to the implementation of National Instrument 43-101 standards. These historical estimates therefore do not meet current standards as defined under sections 1.2 and 1.3 of NI 43-101; consequently, the issuer is not treating the historical estimate as current mineral resources or mineral reserves.
“We’re happy to map out our plans and excited to move forward at the Manitoba properties,” said Alex Klenman, President & CEO.  “Carey and the New Age team have been providing some great intel on the projects and we intend to get right to work.  We’ll spend some time mapping and sampling the priority targets to ensure we are in the best position for success on the initial drill program,” continued Mr. Klenman.
With the commencement of the Manitoba lithium work program the Company will have two active projects, with work ongoing at the East Preston uranium project in the Athabasca Basin, Saskatchewan.  In addition, the Company continues to do due diligence on potential acquisitions of other clean energy, clean fuel exploration projects. 
“As stated previously, we would like an active portfolio with multiple projects that expose the company to different sectors within the clean energy space,” said Mr. Klenman.  “We are and have been invested in uranium, and we’ve added lithium interests.  We are not done building our project portfolio and will continue to evaluate opportunities here in the near term that add additional value,” continued Mr. Klenman. 
Company Hires Trapeze Capital for Market Making Services
The Company is also pleased to announce the retention of Trapeze Capital Corp. of Toronto, Canada to provide market-making services to the Company.
Under the terms of their agreement (the “Agreement”), Trapeze will receive cash compensation of $5,500 per month. Trapeze does not currently own any securities of Azincourt, however, Trapeze and its clients may acquire a direct interest in the securities of Azincourt.  Azincourt and Trapeze are unrelated and unaffiliated entities. Trapeze is a member of the Investment Industry Regulatory Organization of Canada, a participating organization of the Toronto Stock Exchange and a member of TSX Venture Exchange. The capital and securities required for any trade undertaken by Trapeze as principal will be provided by Trapeze. The Agreement is for an initial term of 180 days, with automatic renewal terms unless terminated, and remains subject to the approval of the TSX Venture Exchange.
Option Grant
The Company also announces that it will grant 1,000,000 incentive share purchase options to certain consultants of the Company, subject to TSX Venture Exchange acceptance.  Each option is exercisable to purchase one common share at a price of $0.20 for a period of 24 months in accordance with the Company’s stock option plan.
The contents contained herein, which relates to Exploration Results or Mineral Resources, is based on information compiled, reviewed or prepared by Carey Galeschuk, Principal Consulting Geoscientist for New Age Metals.  Mr. Galeschuk is a Qualified Person, as defined by National Instrument 43-101 and has reviewed and approved the technical content of this news release.
About Azincourt Energy Corp.
Azincourt Energy is a Canadian-based resource company specializing in the strategic acquisition, exploration and development of alternative energy/fuel properties, including uranium, lithium, cobalt and other elements.
ON BEHALF OF THE BOARD OF AZINCOURT ENERGY CORP.
“Alex Klenman”                          
Alex Klenman, President & CEO
Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
This press release includes “forward-looking statements”, including forecasts, estimates, expectations and objectives for future operations that are subject to a number of assumptions, risks and uncertainties, many of which are beyond the control of Azincourt.  Investors are cautioned that any such statements are not guarantees of future performance and that actual results or developments may differ materially from those projected in the forward-looking statements.  Such forward-looking information represents management’s best judgment based on information currently available.  No forward-looking statement can be guaranteed and actual future results may vary materially.
For further information please contact:
Alex Klenman, President & CEO
Tel: 604-638-8063
info@azincourtenergy.com
Azincourt Energy Corp.
1430 – 800 West Pender Street
Vancouver, BC
V6C 2V6

$FNRC Recent News: 1st NRG Corp Announces LOI for over 600 Wells and Gives Corporate Update:

1st NRG Corp.
Business Description

1st NRG Corp. (OTCBB: FNRC.PK) is an exploration and production company headquartered in Denver, Colorado. Our activity has been centered upon the development of coal bed methane reserves in Wyoming where through our wholly owned subsidiary operate and hold a working interest in 43 producing wells and 3,018 undeveloped acres. The undeveloped acreage could be permitted for up to 36 additional locations which are characterized by what we believe to be low geologic risk, a repeatable development opportunity and are offsetting wells which all demonstrated developed coal seams in the Schwartz, Anderson, Canyon, Cook and Wall formations.

In 2014 we expanded our activities into a development of acreage in SE Ohio encompassing approximately 7,000 acres. We hold a 35% working interest in a development well where we are proceeding in the completion of the Beekmantown Dolomite. We currently hold 100% of the offset development rights.Conasauga and Beekmantown formations in Ohio.

The Company has recently taken over operations in Wyoming where we hold interests in 43 wells and 2,821 undeveloped acres.
The undeveloped acreage within the field could be permitted for 35 locations which are characterized by what we believe to be
low geologic risk, a repeatable development opportunity and are offsetting wells which all demonstrated developed coal seams
in the Schwartz, Anderson, Canyon, Cook and Wall formations.

$FNRC Recent News: 1st NRG Corp Announces LOI for over 600 Wells and Gives Corporate Update:
https://finance.yahoo.com/news/1st-nrg-corp-announces-loi-133000248.html

DENVER, CO--(Marketwired - Jan 25, 2017) - 1st NRG Corp. ( OTC PINK : FNRC ), an exploration and production company headquartered in Denver, Colorado, has issued its monthly corporate update to shareholders on the Company's progress.

The Company has entered into a Letter of Intent to purchase over 600 coal bed methane wells through its wholly owned subsidiary 1st NRG Wyoming. These wells were producing over 2,500 mcfd prior to being shut in and we are currently negotiating the purchase and sale agreement.

In November, the company announced the potential acquisition of a natural gas gathering system. The system covers over 364 miles and gives the Company access to over 100,000 acres of potential development. We are negotiating the purchase and sale agreement right now and hope to close in Q1 2017.

The Company expanded its activities into Ohio participating in a development of prospective acreage encompassing approximately 7,000 acres. In 2014, a vertical test well was drilled, logged, cored and cased to a depth of approximately 7,620 feet, testing the Utica Shale but ultimately completed in the Beekmantown Dolomite. The well has been acidized and pumping equipment has been installed, we estimate our share of reserves to be 251 MCFE and production to begin January 2017 weather permitting.

The Company plans to bring the Clabaugh Ranch field in Wyoming back into production Q1 2017 where we estimate our reserves at Clabaugh Ranch to be approximately 18.7 BCF.

The Company is in discussions to raise $25-30 million dollars for the announced acquisitions and for these and others that are planned.

Contact Info
1531 Stout Street
#607
Denver, CO 80202
Website: http://1stnrg-corp.com
Phone: 816-256-8561
Email: investorrelations@1stnrg-com



FNRC Security Details
Share Structure
  Market Value1 $2,299,328 a/o Feb 01, 2017
  Authorized Shares 20,000,000,000 a/o Nov 11, 2016
  Outstanding Shares 5,748,319,880 a/o Nov 11, 2016
  -Restricted Not Available
  -Unrestricted Not Available
  Held at DTC Not Available
  Float 747,569,685 a/o Nov 11, 2016

$POTN Diamond CBD Inc. Exhibits in Las Vegas at the Tobacco Plus Expo on January 30 - February 1

Ft Lauderdale, FL -- January 31, 2018 -- InvestorsHub NewsWire -- PotNetwork Holding, Inc. (OTC Pink: POTN) is pleased to announce that Diamond CBD will be exhibiting at “TPE 2018”, a leading event intended to enable enthusiasts and entrepreneurs to interact widely with industry counterparts and experts.  Featuring informative keynote speeches and educational sessions on topics and issues impacting today’s tobacco, vape, and alternative industries, TPE 2018 presents the IGNITE | Sparking Innovation & Insight event.
 
Diamond CBD will be showcasing at Booth 8126, conveniently located near the Food service section. Management is enthusiastically continuing to broaden the Company’s prospective audience. The global cigarette market today represents a multi-billion dollar industry, and according to IMARC group, its total revenues reached values worth US$ 816 Billion in 2016. A recently published a market intelligence report, “Global E cigarette and Vape market 2017-2025”, suggests that the vaping industry is expected to become a $46.9 billion industry by 2025.” 
 
Highly recognized as a must-attend show for retailers, distributors, and wholesalers seeking to launch the new year with knowledge on the latest products and trends, TPE brings together the top brands in the tobacco, vapor and alternative industries and gives attendees the chance to connect with these top brands in an exciting two-day trade show.
 
This event  has been sold out. For more information, visit: http://tobaccoplusexpo.com/.
 
Finalization on the audit process continues. “We plan to complete our unaudited financials for 2017 and expect to have them posted early. We anticipate within the next couple weeks. We strive to do all within our control to keep our shareholders informed in a timely manner.”stated Richard Goulding, Chief Executive Officer, PotNetwork Holding Inc. He concluded, “As per the audit, we understand it’s a lengthy process, and continue to patiently wait. We remain committed to promptly informing investors as soon as finalization completes.”
 
About Diamond CBD Inc.:  Diamond CBD focuses on the research, development, and multi-national marketing of premium hemp extracts that contain a broad range of cannabinoids and natural hemp derivatives.  Diamond CBD’s team consists of hemp industry pioneers and natural product experts, chemists, doctors and scientists, dedicated to producing the finest and purest cannabidiol (CBD) oils. The result is a robust selection considered among the most powerful natural CBD oilstinctures, edibles, and vape liquids found anywhere. For more information, please visit its website at www.DiamondCBD.com.
 
About PotNetwork Inc.: PotNetwork Inc. brings to market PotNetwork.com, a counter-culture, cutting-edge digital magazine, publishing up-to-date news and articles on the cannabis industry. PotNetwork.com operates as a wholly owned subsidiary of the Company; a media resource providing a full range of industry related topics. 
 
About PotNetwork Holding Inc:  PotNetwork Holding Inc. (OTC Pink: POTN) is a publicly traded company that acts as a holding company for its subsidiaries, First Capital Venture Co., the owner of Diamond CBD, Inc., the maker of Diamond CBD oils, and PotNetwork.com
 
Safe Harbor Act: Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter forward-looking statements, whether as a result of new information, future events or otherwise. 
 
Contact: PotNetwork Holding Inc. Investor Relations: Marisol Elwell, 1-800-915-3060
investor@PotNetworkHolding.com

$FUSZ nFusz CEO To Share Plan to Disrupt Digital Advertising Through Blockchain Technology On iHeartRadio CEO Money Talk Radio Show...

HOLLYWOOD, Calif., Jan. 31, 2018 (GLOBE NEWSWIRE) -- nFusz, Inc. (OTCQB:FUSZ), the Hollywood-based digital technology company, announces that its CEO Rory J. Cutaia, will update listeners during his weekly guest appearance on iHeartRADIO’s popular CEO Money - America’s Business Show, hosted by Michael Yorba, about his plans to incorporate blockchain technology into their notifiCRM platform. The nFusz CEO will share his vision to utilize blockchain technology and crypto-currency to command a greater number of views for the interactive digital video ads distributed online by their notifiCRM subscribers. Mr. Cutaia’s plan is to utilize blockchain technology and crypto-currency to compensate viewers of the interactive ads and then allow the viewers to utilize that currency toward the purchase of the products and services featured in the interactive video ads.
“The massive revenue stream generated in online advertising is based almost entirely on the number of views a piece of advertising content generates,” states nFusz CEO Rory J. Cutaia. “Isn’t it about time that we allow the people responsible for generating that revenue – the viewers themselves – to participate in that income opportunity,” continues Mr. Cutaia. “Our plan is to create an entirely new ecosystem for the distribution of advertising revenue utilizing some of the latest innovations in blockchain technology and crypto-currency,” continues Mr. Cutaia.
The company has just launched ENTOURAGE, a special version of its notifiCRM platform designed specifically for network marketing sales representatives. One of the videos in their Entourage interactive video marketing campaign can be viewed by clicking here.
Anyone can sign-up for a notifiCRM Entourage account from the nFusz website here, which features a dropdown menu making it easy for independent representatives with many of the major network marketing organizations to get started.
This segment will air live today on iHeartRADIO’s popular CEO Money - America’s Business Show, hosted by Michael Yorba, and heard on Talk Radio 1190 AM in Dallas/Fort Worth, TX and online at www.wfn1.com at 3pm ET/12pm PT.
About nFusz, Inc.
nFusz, Inc. (FUSZ) is a Hollywood-based digital tech company. Our proprietary next generation interactive video technology is the core of our new broadcast and cloud-based, Software-as-a-Service (SaaS) products. We offer subscription-based Customer Relationship Management (CRM), sales lead generation, and social engagement software on mobile and desktop platforms for sales-based organizations, consumer brands, and artists seeking greater levels of engagement and higher conversion rates. Our software platform can accommodate any size campaign or sales organization, and its enterprise-class scalability meets the needs of today's global organizations. Our service is built around our proprietary “Video-First” notifi technology, which places interactive video front and center in all customer and prospect communications. With our flagship product, notifiCRM, we've re-invented what a CRM, lead-gen tool should be in today's video-centric business and social environment. Now watch for our live broadcast interactive video platform that will redefine what “engagement” means in consumer video consumption. For more information on nFusz, Inc., visit www.nFusz.com.
About WFN1 News Corp
WFN1 & “CEO Money” is about focusing on businesses, people and stories that reflect positive financial outcomes. Discovering new and interesting companies and industries is very fascinating and can be very rewarding to investors. Timely, innovative and productive ideas steadily spring from CEOs and business leaders with a desire to be linked to the investing public’s awareness. WFN1 can offer this very unique business forum with a win-win proposition that promotes growth in our economies and encourages prosperity through investor participation.
Forward-Looking and Cautionary Statements 
This press release may contain "forward-looking" information within the meaning of the Private Securities Litigation Reform Act of 1995. In accordance with the safe harbor provisions of this Act, statements contained herein that look forward in time that include everything other than historical information, involve risks and uncertainties that may affect the Company's actual results. There can be no assurance that such statements will prove to be accurate and there are a number of important factors that could cause actual results to differ materially from those expressed in any forward-looking statements made by the Company, including, but not limited to, plans and objectives of management for future operations or products, the market acceptance or future success of our products, and our future financial performance. The Company cautions that these forward-looking statements are further qualified by other factors including, but not limited to, those set forth in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2016, and other filings with the U. S. Securities and Exchange Commission (available at www.sec.gov). The Company undertakes no obligation to publicly update or revise any statements in this release, whether as a result of new information, future events, or otherwise.
For more information, please visit: www.nFusz.com
CONTACT INFORMATION
Please address media inquiries to: info@nFusz.com
855.250.2300, extension 7
Please address investor inquiries to: investors@nfusz.com 
855.250.2300, extension 2

$HAON Halitron, Inc. (HAON) Buying Back Shares, Following the Berkshire Hathaway Model

Halitron, Inc. (HAON) Buying Back Shares, Following the Berkshire Hathaway Model
"Building Shreholder Value through Strategic Acquisitions"
Miami, FL -- InvestorsHub NewsWire January 31, 2018 -- EmergingGrowth.com, a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth markets and companies, reports on Halitron, Inc. (OTC Pink: HAON).
Halitron's (OTC Pink: HAON) mission is to build shareholder value through strategic acquisitions of high growth companies that feature distinguishable product characteristics within lucrative sectors of the marketplace.
The company takes a three-prong approach in its transactions.
  1. Halitron quickly evaluates market dynamics and value in order to negotiate payment terms of any target acquisition.
  2. Halitron uses efficiency in evaluating business metrics including the business model, management team, and areas of differentiation.
  3. Halitron has a seamless method of due diligence, and facilitation to begin the process of integration.

HAON may not be at these levels much longer.
See the Press Release and more on Halitron, Inc. (OTC Pink: HAON) at EmergingGrowth.com
Founded in 2003, Halitron (OTC Pink: HAON) weathered the economic down turn of 2008 within the digital gaming industry, and began a restructuring with Warren Wheeler elected Chairman and CEO in 2014. His vision was to implement a growth model and acquired NDG Holdings, a business processing organization, (BPO) focusing on digital development and marketing in 2015. By 2017, the company was focused on multisector diversification including Beverages, Digital Storage, Manufacturing and Direct Marketing.
Halitron, Inc. (OTC Pink: HAONand has had a long journey, but is just beginning to realize the fruits of its labor.
Today Bernard Findley sits at the helm as Chairman and CEO of Halitron, Inc. (OTC Pink: HAON). Mr. Findley brings 20 years of experience working with small to mid-sized businesses from acquisition, to maximizing growth, and the ultimate sale of the business.
From 2008 through 2012, he rolled up and then exited 16 brands that, without his guidance, were bankrupt or out of business. Today, these brands exist and are operating under new owners.  He then began to develop the latest business model of a roll-up strategy through acquisitions utilizing a small publicly traded company, Halitron Inc.
Recently, Halitron, Inc. (OTC Pink: HAON) announced that it booked $342,000 in revenue for the fourth quarter 2017 which represents a 110% increase in sales over the third quarter 2017.
The company stated in its press release "With a market cap of only approximately $1,324,000, Management is excited to announce that its sales for the three months ended December 31, 2017, have been recorded at approximately $342,000, which represents an increase of 110% over its previous quarter sales of approximately $163,000, for the three months ended September 30, 2017."
If sales continue at only half this pace throughout 2018, the company could be looking at over $3 million in sales for 2018.
Some recent developments of Halitron, Inc. (OTC Pink: HAON)
Halitron, Inc. (OTC Pink: HAONjust announced the successful negotiations to modify an existing agreement to reflect the following impact on Halitron's financial books and records.
Halitron has returned 56 million restricted common shares and 80 million Life's Time Capsule Services, Inc.'s ("LTCP") Preferred Stock C shares to LTCP in exchange for the receipt of a note payable for $3 million, bearing interest of 4%, which matures in July 2020.
In the transaction, the assets sold to LTCP in the original transaction will revert to a Halitron asset on its balance sheet. In 2020, upon receipt of the $3 million principal and interest along with Halitron's Board of Directors' approval, Management will submit corporation action paperwork to FINRA for the issuance of a cash dividend to its shareholders, of which record, and payment dates will be announced post receipts of the settlement of the note payable for $3 million.
Halitron (OTC Pink: HAONhas also begun to buy back shares in the open market according to the "black-out" periods disclosed in its filing to OTC Markets with the objective to increase its share price to $0.01 per share. The $0.01 share price is one of the requirements by OTC markets to up list to the OTC QB. The number of shares and price paid will be listed in its quarterly filings.
According to OTC Markets, the current market cap of Halitron, Inc. (OTC Pink: HAON) is approximately $2.9 million and as such, its shares can have a dramatic upside.
Previously the company announced that margins are also expected to increase due to its reduction of a manufacturing cell expenses by 65% after a move from Newton CT, to New Hide Park NY.
Halitron, Inc. (OTC Pink: HAON) is also currently completing its audit which will allow it to qualify for an up list to the OTCQB in the early part of 2018.

HAON may not be at these levels much longer.
See the Press Release and more on Halitron, Inc. (OTC Pink: HAON) at EmergingGrowth.com